Chemoresistance profile of circulating tumor cells: Toward a clinical benefit?
Authors:
Open Access
- 21 July 2008
- journal article
- letter
- Published by Wiley in International Journal of Cancer
- Vol. 123 (7) , 1730-1732
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early RelapseJournal of Clinical Oncology, 2008
- Measuring Circulating Tumor Cells As a Surrogate End Point for Adjuvant Therapy of Breast Cancer: What Do They Mean and What Should We Do About Them?Journal of Clinical Oncology, 2008
- Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cellsAnnals of Oncology, 2008
- Circulating tumor cells: detection, molecular profiling and future prospectsExpert Review of Proteomics, 2007
- Chemotherapy-induced resistance by ATP-binding cassette transporter genesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
- Circulating Tumor Cells in Metastatic Breast Cancer: Biologic Staging Beyond Tumor BurdenClinical Breast Cancer, 2007
- Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBritish Journal of Cancer, 2007
- Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast CancerClinical Cancer Research, 2006
- The ?microscopic? revolution in breast carcinomaCancer, 2004
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004